Lilly and Novo Show How AI Is Rewiring Big Pharma
Eli Lilly and Novo Nordisk, the two companies that dominate the global market for GLP-1 weight loss and diabetes drugs, are each deploying artificial intelligence (AI) across different stages of drug ...
The Best Fourthwall Products for Creators, Backed by Real Data
After quite a few years of working alongside creators building print on demand stores, I’ve noticed something. Most people tend to assume the “best products” to sell are always the same.
Obvi...
Chinese AI Firm Zhipu’s 2025 Revenue Jumps 132%
Chinese AI model developer Zhipu said its revenue last year more than doubled to 724 million yuan ($105 million), while its net loss widened sharply due to growing research and development expenses. T...